← Back to all signals
RESEARCH PAPER ANALYSIS

Apatinib plus ifosfamide and etoposide versus ifosfamide and etoposide in patients with advanced osteosarcomas (OAIE/PKUPH-sarcoma 11): a randomized phase II study.

AI interpretation is pending for this paper.

Open original publication →
PMID41290609
JournalNature communications
Publication Date2025-11-25
Ingested2026-08-02 12:05 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

Relapsed or refractory osteosarcoma carries a poor prognosis after standard chemotherapy. We conducted a multicenter, randomized, phase II trial (NCT05277480) to compare apatinib plus ifosfamide/etoposide (IE) with IE alone in patients who had progressed following at least one prior line of chemotherapy. Patients were randomized 2:1 to receive apatinib (500 mg orally once daily) plus IE (ifosfamide 1.8 g/m²/day and etoposide 100 mg/m²/day, days 1-3 every 3 weeks) or IE alone (same doses, days 1-5 every 3 weeks). The primary endpoint was progression-free survival (PFS). Between April 14, 2022, and August 22, 2023, 81 patients were enrolled (53 in apatinib plus IE group and 28 in IE group). After a median follow-up of 19.9 months, the median PFS was 5.5 months (95% confidence interval [CI]: 3.9, 6.4) with apatinib plus IE compared with 3.4 months (95% CI: 1.4, 4.6) with IE (hazard ratio, 0.60; 95% CI: 0.37, 0.98; P = 0.0402). The trial met its pre-specified primary endpoint. These results suggest that apatinib plus IE may improve PFS in relapsed or refractory osteosarcoma, but as a randomized phase II study, the findings are exploratory and require confirmation in phase III trials.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 A Novel Homozygous GALNT3 Deletion in Hyperphosphatemic Familial Tumoral Calcinosis Presenting with Subcutaneous Calcifications and Raynaud's Phenomenon in an Adult Patient: A Case Report. Molecular syndromology 47.5 2 Overcoming immunotherapy barriers in pediatric brain tumors: epigenetic strategies. Frontiers in oncology 65.42 3 CAR T-cell therapy in pediatric brain tumors: a narrative review with comparative analysis of clinical trial eligibility criteria. Frontiers in oncology 91.0 4 Liver resection is associated with better survival than TACE for hepatocellular carcinoma modestly beyond Milan criteria: a multicenter propensity-matched analysis. Frontiers in oncology 68.52 5 Case Report: a rare pediatric case series of multiple endocrine neoplasia type 2B presenting with laryngotracheal involvement. Frontiers in endocrinology 53.0 6 Kidney transplantation outcomes in children with WT1-associated kidney disease: a single-center cohort study. Frontiers in pediatrics 57.0 7 Prevalence and effects on outcomes of intracranial tumors and structural alterations in children with central precocious puberty and early and fast puberty. Frontiers in endocrinology 77.2 8 Laparoscopic liver resection for pediatric liver tumors: a systematic review and meta-analysis. Frontiers in pediatrics 73.0 9 Expanding HPV prevention across the life course: evidence on vaccine effectiveness in adults. Frontiers in public health 62.1 10 Healthcare-associated post-neurosurgical meningitis caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in an Infant: A case report. IDCases 51.9 11 Does the surgical route matter in cerebellar mutism syndrome? Comparing transvermian and telovelar approaches for pediatric posterior fossa tumors. Brain & spine 63.0 12 Oral Candida infection and colonization in pediatric patients with cancer: risk factors, species distribution, and antifungal susceptibility. Journal de mycologie medicale 52.4 13 AEG-1/MTDH: A central regulator of tumor progression, metabolic adaptation, and therapeutic resistance in gliomas. Tissue & cell 67.44 14 Determinants of mammography screening uptake among women attending family health centers in Ankara, Türkiye: a cross-sectional study. BMC health services research 59.0 15 Concurrent Germline RB1 & Mosaic TP53 in a Child With Multiple Childhood Cancers. American journal of medical genetics. Part A 65.2 16 Outcomes of Children With Orbital Rhabdomyosarcoma, 1991-2016: A Report From the International Soft Tissue Sarcoma Consortium (INSTRuCT). Pediatric blood & cancer 76.3 17 Listeria monocytogenes meningitis beyond the neonatal period: a multicenter case series of previously unpublished pediatric cases from Türkiye. European journal of pediatrics 56.9 18 Longitudinal evaluation of sleep disturbances in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Journal of cancer survivorship : research and practice 66.9 19 Age and sex differences in the global cancer burden. Cancer causes & control : CCC 39.4 20 Cancer information seeking and awareness of multi-cancer detection tests among U.S. adults: a cross-sectional study. Cancer causes & control : CCC 66.0 21 Combined glue embolization and surgical excision for management of genitourinary and perineal vascular anomalies in pediatric and adolescent patients assigned female at birth. Journal of pediatric and adolescent gynecology 59.3 22 "The less they talk about it, the more we think about it": a qualitative interview study of the existential agency of children and young people when they are relatives of a family member dying from cancer in a hospice in Denmark. BMC palliative care 57.5 23 Cellular adhesion-dependent 3D morphogenesis indicating brain tumor aggressiveness and chemosensitivity in spherical cavity culture. Experimental hematology & oncology 62.4 24 Multimodal single-cell profiling identifies nclTECs and links chromatin remodeling to TEC differentiation and self-antigen expression modes. iScience 57.4 25 Low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma in a pediatric liver transplant recipient: a case report. Urology case reports 45.5 26 Lower social participation and physical activity in patients with craniopharyngioma or CNS germ cell tumor: Their association with apathy. PCN reports : psychiatry and clinical neurosciences 61.9 27 Satisfaction with follow-up consultations among Swiss childhood cancer survivors: A prospective cohort study. Preventive medicine reports 65.5 28 Pediatric pulmonary tuberculosis masquerading as chest neoplasms. Radiology case reports 55.4 29 School re-entry for children and adolescents with cancer: A qualitative study from the perspectives of school personnel. Asia-Pacific journal of oncology nursing 58.4 30 Co-designing a prototype teaching intervention on triadic communication for healthcare professionals working with young people with cancer. PEC innovation 58.7 31 Family and sexual functioning among women diagnosed with cervical cancer in Urban Ghana: A mixed-methods study. Women's health (London, England) 62.0 32 Targeting ABCB6 induces ferroptosis in osteosarcoma cells via HIF1A/GPX4 pathway. Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 68.0
PATIENT-FRIENDLY SUMMARY

Apatinib plus ifosfamide and etoposide versus ifosfamide and etoposide in patients with advanced osteosarcomas (OAIE/PKUPH-sarcoma 11): a randomized phase II study.

For education only—not personal medical advice.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic